The FDA has expanded the indications for Insulet SmartAdjust technology to include the management of Type 2 diabetes in people 18 and older.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA clears 1st automated device for Type 2 diabetes
